ID   M3K5_HUMAN              Reviewed;        1374 AA.
AC   Q99683; Q5THN3; Q99461;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   05-OCT-2010, entry version 116.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 5;
DE            EC=2.7.11.25;
DE   AltName: Full=Apoptosis signal-regulating kinase 1;
DE            Short=ASK-1;
DE   AltName: Full=MAPK/ERK kinase kinase 5;
DE            Short=MEK kinase 5;
DE            Short=MEKK 5;
GN   Name=MAP3K5; Synonyms=ASK1, MAPKKK5, MEKK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   MEDLINE=97094945; PubMed=8940179; DOI=10.1074/jbc.271.49.31607;
RA   Wang X.S., Diener K., Jannuzzi D., Trollinger D., Tan T.-H.,
RA   Lichenstein H., Zukowski M., Yao Z.;
RT   "Molecular cloning and characterization of a novel protein kinase with
RT   a catalytic domain homologous to mitogen-activated protein kinase
RT   kinase kinase.";
RL   J. Biol. Chem. 271:31607-31611(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   MEDLINE=97130104; PubMed=8974401; DOI=10.1126/science.275.5296.90;
RA   Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T.,
RA   Takagi M., Matsumoto K., Miyazono K., Gotoh Y.;
RT   "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates
RT   SAPK/JNK and p38 signaling pathways.";
RL   Science 275:90-94(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH DAXX, AND MUTAGENESIS OF LYS-709.
RX   MEDLINE=98416247; PubMed=9743501; DOI=10.1126/science.281.5384.1860;
RA   Chang H.Y., Nishitoh H., Yang X., Ichijo H., Baltimore D.;
RT   "Activation of apoptosis signal-regulating kinase 1 (ASK1) by the
RT   adapter protein Daxx.";
RL   Science 281:1860-1863(1998).
RN   [6]
RP   INTERACTION WITH ARRB2.
RX   PubMed=11090355; DOI=10.1126/science.290.5496.1574;
RA   McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E.,
RA   Lin F.-T., Davis R.J., Lefkowitz R.J.;
RT   "Beta-arrestin 2: a receptor-regulated MAPK scaffold for the
RT   activation of JNK3.";
RL   Science 290:1574-1577(2000).
RN   [7]
RP   INTERACTION WITH HIV-1 NEF, AND INHIBITION BY HIV-1 NEF.
RX   MEDLINE=21195973; PubMed=11298454; DOI=10.1038/35071111;
RA   Geleziunas R., Xu W., Takeda K., Ichijo H., Greene W.C.;
RT   "HIV-1 Nef inhibits ASK1-dependent death signalling providing a
RT   potential mechanism for protecting the infected host cell.";
RL   Nature 410:834-838(2001).
RN   [8]
RP   FUNCTION, HOMODIMERIZATION, ENZYME REGULATION, AND PHOSPHORYLATION AT
RP   THR-838.
RX   PubMed=11920685; DOI=10.1002/jcp.10080;
RA   Tobiume K., Saitoh M., Ichijo H.;
RT   "Activation of apoptosis signal-regulating kinase 1 by the stress-
RT   induced activating phosphorylation of pre-formed oligomer.";
RL   J. Cell. Physiol. 191:95-104(2002).
RN   [9]
RP   INTERACTION WITH DAB2IP.
RX   PubMed=12813029;
RA   Zhang R., He X., Liu W., Lu M., Hsieh J.-T., Min W.;
RT   "AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating
RT   dissociation of ASK1 from its inhibitor 14-3-3.";
RL   J. Clin. Invest. 111:1933-1943(2003).
RN   [10]
RP   INTERACTION WITH DAB2IP.
RX   PubMed=15310755; DOI=10.1074/jbc.M407617200;
RA   Zhang H., Zhang R., Luo Y., D'Alessio A., Pober J.S., Min W.;
RT   "AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-
RT   induced ASK1-JNK activation.";
RL   J. Biol. Chem. 279:44955-44965(2004).
RN   [11]
RP   ENZYME REGULATION, PHOSPHORYLATION AT SER-966 AND SER-1033,
RP   MUTAGENESIS OF SER-966 AND SER-1033, AND INTERACTION WITH YWHAG.
RX   PubMed=15094778; DOI=10.1038/sj.onc.1207668;
RA   Fujii K., Goldman E.H., Park H.R., Zhang L., Chen J., Fu H.;
RT   "Negative control of apoptosis signal-regulating kinase 1 through
RT   phosphorylation of Ser-1034.";
RL   Oncogene 23:5099-5104(2004).
RN   [12]
RP   INTERACTION WITH PPM1L.
RX   PubMed=17456047; DOI=10.1042/BJ20070231;
RA   Saito J., Toriumi S., Awano K., Ichijo H., Sasaki K., Kobayashi T.,
RA   Tamura S.;
RT   "Regulation of apoptosis signal-regulating kinase 1 by protein
RT   phosphatase 2Cepsilon.";
RL   Biochem. J. 405:591-596(2007).
RN   [13]
RP   ENZYME REGULATION, INTERACTION WITH MAP3K5, PHOSPHORYLATION AT
RP   THR-838, AND MUTAGENESIS OF LYS-709.
RX   PubMed=17210579; DOI=10.1074/jbc.M607177200;
RA   Takeda K., Shimozono R., Noguchi T., Umeda T., Morimoto Y., Naguro I.,
RA   Tobiume K., Saitoh M., Matsuzawa A., Ichijo H.;
RT   "Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-
RT   activated protein kinase kinase kinase in a heteromeric complex with
RT   ASK1.";
RL   J. Biol. Chem. 282:7522-7531(2007).
RN   [14]
RP   INTERACTION WITH ARRB2.
RX   PubMed=18408005; DOI=10.1074/jbc.M710006200;
RA   Guo C., Whitmarsh A.J.;
RT   "The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal
RT   kinase-3 activation by binding to its nonconserved N terminus.";
RL   J. Biol. Chem. 283:15903-15911(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1033, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1033, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-836; THR-838; SER-958;
RP   THR-976; SER-977; SER-978; SER-979; SER-984; SER-986; THR-989 AND
RP   SER-1033, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   INTERACTION WITH PGAM5, AND PHOSPHORYLATION.
RX   PubMed=19590015; DOI=10.1073/pnas.0901823106;
RA   Takeda K., Komuro Y., Hayakawa T., Oguchi H., Ishida Y., Murakami S.,
RA   Noguchi T., Kinoshita H., Sekine Y., Iemura S., Natsume T., Ichijo H.;
RT   "Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic
RT   activity as a protein serine/threonine phosphatase to activate ASK1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12301-12305(2009).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-1006; THR-1214; VAL-1250; ILE-1314
RP   AND ASN-1315.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Phosphorylates and activates MAP2K4 and MAP2K6, which in
CC       turn activate the JNK and p38 MAP kinases, respectively.
CC       Overexpression induces apoptotic cell death.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Contains an N-terminal autoinhibitory domain.
CC       Activated by phosphorylation at Thr-838, inhibited by
CC       phosphorylation at Ser-966 and Ser-1033. Binds to, and stabilizes
CC       MAP3K6 and is activated by MAP3K6 by phosphorylation on Thr-838.
CC   -!- SUBUNIT: Homodimer when inactive. Binds both upstream activators
CC       and downstream substrates in multimolecular complexes. Associates
CC       with and inhibited by HIV-1 Nef. Interacts with DAB2IP and PPM1L.
CC       Interacts with ARRB2.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-476263, EBI-476263;
CC       P31749:AKT1; NbExp=2; IntAct=EBI-476263, EBI-296087;
CC       Q9UER7:DAXX; NbExp=4; IntAct=EBI-476263, EBI-77321;
CC       P25445:FAS; NbExp=1; IntAct=EBI-476263, EBI-494743;
CC       P15626:Gstm2 (xeno); NbExp=1; IntAct=EBI-476263, EBI-1209729;
CC       P09211:GSTP1; NbExp=1; IntAct=EBI-476263, EBI-353467;
CC       Q9WTR2:Map3k6 (xeno); NbExp=1; IntAct=EBI-476263, EBI-1254790;
CC       O08815:Slk (xeno); NbExp=1; IntAct=EBI-476263, EBI-986112;
CC       Q12933:TRAF2; NbExp=1; IntAct=EBI-476263, EBI-355744;
CC       P63104:YWHAZ; NbExp=1; IntAct=EBI-476263, EBI-347088;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in heart and pancreas.
CC   -!- INDUCTION: By TNF. Inhibited by HIV-1 Nef.
CC   -!- PTM: Dephosphorylated and activated by PGAM5.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U67156; AAC50894.1; -; mRNA.
DR   EMBL; D84476; BAA12684.2; -; mRNA.
DR   EMBL; AL024508; CAI20176.1; -; Genomic_DNA.
DR   EMBL; AL121933; CAI20176.1; JOINED; Genomic_DNA.
DR   EMBL; AL121933; CAI15470.1; -; Genomic_DNA.
DR   EMBL; AL024508; CAI15470.1; JOINED; Genomic_DNA.
DR   EMBL; BC054503; AAH54503.1; -; mRNA.
DR   EMBL; BC088829; AAH88829.1; -; mRNA.
DR   IPI; IPI00412433; -.
DR   RefSeq; NP_005914.1; -.
DR   UniGene; Hs.186486; -.
DR   PDB; 2CLQ; X-ray; 2.30 A; A/B=659-951.
DR   PDBsum; 2CLQ; -.
DR   ProteinModelPortal; Q99683; -.
DR   DIP; DIP-29516N; -.
DR   IntAct; Q99683; 29.
DR   MINT; MINT-99796; -.
DR   STRING; Q99683; -.
DR   PRIDE; Q99683; -.
DR   Ensembl; ENST00000359015; ENSP00000351908; ENSG00000197442.
DR   GeneID; 4217; -.
DR   KEGG; hsa:4217; -.
DR   UCSC; uc003qhc.1; human.
DR   CTD; 4217; -.
DR   GeneCards; GC06M136919; -.
DR   H-InvDB; HIX0025089; -.
DR   HGNC; HGNC:6857; MAP3K5.
DR   HPA; CAB007824; -.
DR   MIM; 602448; gene.
DR   PharmGKB; PA30601; -.
DR   HOVERGEN; HBG006305; -.
DR   InParanoid; Q99683; -.
DR   OMA; ESMSAEA; -.
DR   OrthoDB; EOG9909VQ; -.
DR   PhylomeDB; Q99683; -.
DR   BRENDA; 2.7.11.25; 247.
DR   BRENDA; 2.7.12.2; 247.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; hivnefpathway; HIV-1 Nef: Negative effector of Fas and TNF-alpha.
DR   Pathway_Interaction_DB; mtor_4pathway; mTOR signaling pathway.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   NextBio; 16633; -.
DR   ArrayExpress; Q99683; -.
DR   Bgee; Q99683; -.
DR   CleanEx; HS_MAP3K5; -.
DR   Genevestigator; Q99683; -.
DR   GermOnline; ENSG00000197442; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008656; F:caspase activator activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0008624; P:induction of apoptosis by extracellular sig...; TAS:ProtInc.
DR   GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Complete proteome;
KW   Host-virus interaction; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1374       Mitogen-activated protein kinase kinase
FT                                kinase 5.
FT                                /FTId=PRO_0000086249.
FT   DOMAIN      680    938       Protein kinase.
FT   NP_BIND     686    694       ATP (By similarity).
FT   ACT_SITE    803    803       Proton acceptor (By similarity).
FT   BINDING     709    709       ATP.
FT   MOD_RES     836    836       Phosphothreonine.
FT   MOD_RES     838    838       Phosphothreonine.
FT   MOD_RES     958    958       Phosphoserine.
FT   MOD_RES     966    966       Phosphoserine.
FT   MOD_RES     976    976       Phosphothreonine.
FT   MOD_RES     977    977       Phosphoserine.
FT   MOD_RES     978    978       Phosphoserine.
FT   MOD_RES     979    979       Phosphoserine.
FT   MOD_RES     984    984       Phosphoserine.
FT   MOD_RES     986    986       Phosphoserine.
FT   MOD_RES     989    989       Phosphothreonine.
FT   MOD_RES    1029   1029       Phosphoserine.
FT   MOD_RES    1033   1033       Phosphoserine.
FT   VARIANT    1006   1006       G -> R (in dbSNP:rs45626535).
FT                                /FTId=VAR_040693.
FT   VARIANT    1214   1214       I -> T (in dbSNP:rs56379668).
FT                                /FTId=VAR_040694.
FT   VARIANT    1250   1250       I -> V (in dbSNP:rs35551087).
FT                                /FTId=VAR_040695.
FT   VARIANT    1314   1314       T -> I (in dbSNP:rs45599539).
FT                                /FTId=VAR_040696.
FT   VARIANT    1315   1315       D -> N (in dbSNP:rs41288957).
FT                                /FTId=VAR_040697.
FT   MUTAGEN     709    709       K->M: Loss of kinase activity. Inhibits
FT                                activation of JNK and apoptosis mediated
FT                                by TNFRSF6 and DAXX.
FT   MUTAGEN     709    709       K->R: Loss of kinase activity. Abolishes
FT                                DAXX-mediated apoptosis.
FT   MUTAGEN     966    966       S->A: Enhanced induction of apoptosis,
FT                                increased kinase activity, and loss of
FT                                YWHAG binding.
FT   MUTAGEN    1033   1033       S->A: Enhanced induction of apoptosis and
FT                                increased kinase activity.
FT   STRAND      671    714
FT   HELIX       720    730
FT   STRAND      731    761
FT   HELIX       762    767
FT   STRAND      768    770
FT   STRAND      773    776
FT   HELIX       777    796
FT   STRAND      797    830
FT   STRAND      838    846
FT   HELIX       848    853
FT   STRAND      855    861
FT   HELIX       862    876
FT   STRAND      880    888
FT   HELIX       889    897
FT   STRAND      898    900
FT   STRAND      905    908
FT   HELIX       909    916
FT   STRAND      917    928
FT   HELIX       929    933
SQ   SEQUENCE   1374 AA;  154537 MW;  265BDC65968AF985 CRC64;
     MSTEADEGIT FSVPPFAPSG FCTIPEGGIC RRGGAAAVGE GEEHQLPPPP PGSFWNVESA
     AAPGIGCPAA TSSSSATRGR GSSVGGGSRR TTVAYVINEA SQGQLVVAES EALQSLREAC
     ETVGATLETL HFGKLDFGET TVLDRFYNAD IAVVEMSDAF RQPSLFYHLG VRESFSMANN
     IILYCDTNSD SLQSLKEIIC QKNTMCTGNY TFVPYMITPH NKVYCCDSSF MKGLTELMQP
     NFELLLGPIC LPLVDRFIQL LKVAQASSSQ YFRESILNDI RKARNLYTGK ELAAELARIR
     QRVDNIEVLT ADIVINLLLS YRDIQDYDSI VKLVETLEKL PTFDLASHHH VKFHYAFALN
     RRNLPGDRAK ALDIMIPMVQ SEGQVASDMY CLVGRIYKDM FLDSNFTDTE SRDHGASWFK
     KAFESEPTLQ SGINYAVLLL AAGHQFESSF ELRKVGVKLS SLLGKKGNLE KLQSYWEVGF
     FLGASVLAND HMRVIQASEK LFKLKTPAWY LKSIVETILI YKHFVKLTTE QPVAKQELVD
     FWMDFLVEAT KTDVTVVRFP VLILEPTKIY QPSYLSINNE VEEKTISIWH VLPDDKKGIH
     EWNFSASSVR GVSISKFEER CCFLYVLHNS DDFQIYFCTE LHCKKFFEMV NTITEEKGRS
     TEEGDCESDL LEYDYEYDEN GDRVVLGKGT YGIVYAGRDL SNQVRIAIKE IPERDSRYSQ
     PLHEEIALHK HLKHKNIVQY LGSFSENGFI KIFMEQVPGG SLSALLRSKW GPLKDNEQTI
     GFYTKQILEG LKYLHDNQIV HRDIKGDNVL INTYSGVLKI SDFGTSKRLA GINPCTETFT
     GTLQYMAPEI IDKGPRGYGK AADIWSLGCT IIEMATGKPP FYELGEPQAA MFKVGMFKVH
     PEIPESMSAE AKAFILKCFE PDPDKRACAN DLLVDEFLKV SSKKKKTQPK LSALSAGSNE
     YLRSISLPVP VLVEDTSSSS EYGSVSPDTE LKVDPFSFKT RAKSCGERDV KGIRTLFLGI
     PDENFEDHSA PPSPEEKDSG FFMLRKDSER RATLHRILTE DQDKIVRNLM ESLAQGAEEP
     KLKWEHITTL IASLREFVRS TDRKIIATTL SKLKLELDFD SHGISQVQVV LFGFQDAVNK
     VLRNHNIKPH WMFALDSIIR KAVQTAITIL VPELRPHFSL ASESDTADQE DLDVEDDHEE
     QPSNQTVRRP QAVIEDAVAT SGVSTLSSTV SHDSQSAHRS LNVQLGRMKI ETNRLLEELV
     RKEKELQALL HRAIEEKDQE IKHLKLKSQP IEIPELPVFH LNSSGTNTED SELTDWLRVN
     GADEDTISRF LAEDYTLLDV LYYVTRDDLK CLRLRGGMLC TLWKAIIDFR NKQT
//
